Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Acihexal 250mg
Active Ingredient(s): Aciclovir 250mg
Dosage Form: Powder for infusion
New Zealand Sponsor: Hexal New Zealand Pty Limited
Manufacturer(s): Wasserburger Arzneimittelwerk Dr Madaus GmbH, Wasserburg am Inn, Germany
Product: Acihexal 500mg
Active Ingredient(s): Aciclovir 500mg
Dosage Form: Powder for infusion
New Zealand Sponsor: Hexal New Zealand Pty Limited
Manufacturer(s): Wasserburger Arzneimittelwerk Dr Madaus GmbH, Wasserburg am Inn, Germany
Product: Seretide Accuhaler
Active Ingredient(s): Fluticasone propionate 100µg
Salmeterol xinafoate 72.5µg equivalent to 50µg of salmeterol base
Dosage Form: Powder for inhalation
New Zealand Sponsor: Glaxo Wellcome New Zealand Limited
Manufacturer(s): Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom
Product: Seretide Accuhaler
Active Ingredient(s): Fluticasone propionate 250µg
Salmeterol xinafoate 72.5µg equivalent to 50µg of salmeterol base
Dosage Form: Powder for inhalation
New Zealand Sponsor: Glaxo Wellcome New Zealand Limited
Manufacturer(s): Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom
Product: Seretide Accuhaler
Active Ingredient(s): Fluticasone propionate 500µg
Salmeterol xinafoate 72.5µg equivalent to 50µg of salmeterol base
Dosage Form: Powder for inhalation
New Zealand Sponsor: Glaxo Wellcome New Zealand Limited
Manufacturer(s): Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom
Dated this 18th day of August 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).